SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in NXL — Nexalin Technology, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in NXL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,282
-$3,249 QoQ
Shares Held
698
+11.0% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NXL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $393,770,148 across 80 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
826,420 | $74,989,349 | |
| 2 | BSX |
Boston Scientific Corp
|
1,661,950 | $70,932,025 | |
| 3 | DXCM |
Dexcom Inc
|
1,043,864 | $70,304,239 | |
| 4 | MDT |
Medtronic plc
|
410,840 | $32,140,013 | |
| 5 | SYK |
Stryker Corp
|
76,719 | $24,154,209 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
314,867 | $20,154,636 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
255,398 | $16,963,535 | |
| 8 | PEN |
Penumbra Inc
|
29,149 | $9,203,796 |
All Filings in NXL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,282 | 20,928 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $10,531 | 18,874 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $57,310 | 62,498 | Shares | Other | 2025-11-14 | |
| 2024-09-30 | $28,354 | 42,383 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $8,018 | 18,224 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $11,675 | 15,588 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||